{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T19:36:58Z","timestamp":1773085018514,"version":"3.50.1"},"reference-count":50,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,7,19]],"date-time":"2012-07-19T00:00:00Z","timestamp":1342656000000},"content-version":"vor","delay-in-days":6136,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[1995,10]]},"abstract":"<jats:p><jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>The effects of SR 33589 and amiodarone on the cardiac \u03b2\u2010adrenoceptor were studied <jats:italic>in vitro<\/jats:italic> and after chronic treatment by means of [<jats:sup>125<\/jats:sup>I]\u2010(\u2212)\u2212iodocyanopindolol ([<jats:sup>125<\/jats:sup>I]\u2010(\u2212)\u2212CYP) binding and measurement of adenylate cyclase activity.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Binding of [<jats:sup>125<\/jats:sup>I]\u2010(\u2212)\u2212CYP was inhibited in a dose\u2010dependent manner by SR 33589 (IC<jats:sub>50<\/jats:sub> = 1.8 \u00b1 0.4 \u03bcM, n<jats:sub>H<\/jats:sub> = 0.93 \u00b1 0.06) and amiodarone (IC<jats:sub>50<\/jats:sub> = 8.7 \u00b1 2.0 \u03bcM, n<jats:sub>H<\/jats:sub> = 0.92 \u00b1 0.03). Saturation binding experiments indicated a non\u2010competitive interaction such that SR 33589 (1 and 3 \u03bcm) and amiodarone (5 and 10 \u03bcm) reduced the <jats:italic>B<\/jats:italic><jats:sub>max<\/jats:sub> of [<jats:sup>125<\/jats:sup>I]\u2010(\u2212)\u2212CYP binding without any effect on the <jats:italic>K<\/jats:italic><jats:sub>D<\/jats:sub>. Kinetic studies showed that the rate of association of [<jats:sup>125<\/jats:sup>I]\u2010(\u2212)\u2212CYP was unchanged while the rate of dissociation was increased both in the presence of SR 33589 (10 \u03bcm) and amiodarone (30 \u03bcM).<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Under the same conditions, the receptor stimulated adenylate cyclase activity was inhibited in a dose\u2010dependent, but non\u2010competitive manner, by SR 33589 (isoprenaline\u2010, glucagon\u2010 and secretin\u2010stimulated enzyme inhibited 50% at 6.8 \u00b1 0.6 \u03bcM, 31 \u00b1 10 \u03bcm and 12 \u00b1 3 \u03bcM, respectively) while the basal, GTP\u2010 and Gpp(NH)p\u2010stimulated enzyme was inhibited by 5\u201310% and the NaF and forskolin\u2010stimulated enzyme by 50% at 500 \u03bcM. Amiodarone exhibited a similar pattern of inhibition.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>After chronic oral treatment (50, 100, 150 mg kg<jats:sup>\u22121<\/jats:sup> per day, 14 days), both SR 33589 and amiodarone produced a dose\u2010dependent decrease in <jats:italic>B<\/jats:italic><jats:sub>max<\/jats:sub> without any effect on <jats:italic>K<\/jats:italic><jats:sub>D<\/jats:sub> as determined from [<jats:sup>125<\/jats:sup>I]\u2010(\u2212)\u2212CYP saturation experiments and a decrease of the isoprenaline\u2010 and glucagon\u2010stimulated adenylate cyclase activity without any effect on basal enzyme activity or activity when stimulated by agents acting directly on regulatory catalytic units.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>Unlike amiodarone, SR 33589 does not contain iodine substituents. Plasma levels of T<jats:sub>3<\/jats:sub>, T<jats:sub>4<\/jats:sub> and rT<jats:sub>3<\/jats:sub> were unchanged after SR 33589 treatment except a decrease in T<jats:sub>4<\/jats:sub> level at the highest dose whilst the T<jats:sub>4<\/jats:sub> T<jats:sub>3<\/jats:sub> ratio and the level of rT<jats:sub>3<\/jats:sub> were dose\u2010dependently increased by amiodarone treatment.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p><jats:italic>In vitro<\/jats:italic>, SR 33589 and amiodarone were characterized as non\u2010competitive \u03b2\u2010adrenoceptor antagonists. Chronic treatment led to a down\u2010regulation of the \u03b2\u2010adrenoceptor; the down\u2010regulation cannot be attributed to an indirect effect mediated by the thyroid hormones. To reconcile these opposing observations, we propose that SR 33589 and amiodarone interact with the \u03b2\u2010adrenoceptor at a site close to the intracellular loops which are involved in the coupling with G<jats:sub>s<\/jats:sub> and contain the phosphorylable sites.<\/jats:p><\/jats:list-item>\n<\/jats:list><\/jats:p>","DOI":"10.1111\/j.1476-5381.1995.tb16397.x","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T14:11:46Z","timestamp":1342793506000},"page":"1949-1956","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the \u03b2\u2010adrenoceptor and adenylate cyclase in rat heart"],"prefix":"10.1111","volume":"116","author":[{"given":"P.","family":"Chatelain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Meysmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.R.","family":"Matt\u00e9azzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ph.","family":"Beaufort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Clinet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,19]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(76)90368-3"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/S0021-9258(17)42012-6","article-title":"A highly conserved tyrosine residue in G protein\u2010coupled receptors is required for agonist\u2010mediated \u03b22\u2010adrenergic receptor sequestration","volume":"269","author":"BARAK L.S.","year":"1994","journal-title":"J. Biol. Chem."},{"key":"e_1_2_1_4_1","first-page":"45","article-title":"Nature of the inhibition by amiodarone of isoproterenol\u2010inducedtachycardiainthedog","volume":"219","author":"BAUTHIER J.","year":"1976","journal-title":"Arch. Int. Pharmacodyn."},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/25.6.503"},{"key":"e_1_2_1_6_1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0022-2828(92)91602-2","article-title":"SR 33589, a new amiodarine\u2010like agent: effect on reperfusion\u2010induced arrhythmias in anaesthetised rats","volume":"24","author":"BRUYNINCKX C.","year":"1992","journal-title":"J. Mol. Cell. Cardiol."},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0922-4106(92)90136-J"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1210431"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1970.tb09892.x"},{"key":"e_1_2_1_10_1","volume-title":"Drug and Anesthetic Effects on Membrane Structure and Function","author":"CHATELAIN P.","year":"1991"},{"key":"e_1_2_1_11_1","first-page":"43","volume-title":"Molecular Description of Biological Membrane Components by Computer Aided Conformational Analysis","author":"CHATELAIN P.","year":"1989"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(89)90328-6"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00587924"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(73)90196-2"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198411000-00023"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2828(89)90785-2"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1214\/aoms\/1177729693"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.60.070191.003253"},{"key":"e_1_2_1_19_1","first-page":"28P","article-title":"SR 33589, a new amiodarone\u2010like agent: effect on ischaemia\u2010induced ventricular arrhythmias in anaesthetized pigs","volume":"111","author":"FINANCE O.","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198500293-00002"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199243010-00007"},{"key":"e_1_2_1_22_1","first-page":"337","article-title":"\u03b2\u2010adrenergic receptors, voltage\u2010operated Ca2+\u2010channels, nuclear triiodothyronine receptors and triiodothyronine concentration in pig myocardium after long\u2010term low\u2010dose amiodarone treatment","volume":"129","author":"GOTZSCHE L.B.\u2010H.","year":"1993","journal-title":"Acta Endocrinol."},{"key":"e_1_2_1_23_1","first-page":"1871","article-title":"Mathematical analysis of concentration\u2010response relationships","volume":"27","author":"HAFNER D.","year":"1977","journal-title":"Arzneim. Forsch."},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.8.2979"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2828(88)80128-7"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00501172"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(90)90204-2"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(79)90010-9"},{"key":"e_1_2_1_30_1","first-page":"2460","article-title":"Modulation of myocardial cyclic AMP and vulnerability to fibrillation in the rat heart","volume":"42","author":"LUBBE W.F.","year":"1983","journal-title":"Fed. Proc"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(87)90375-3"},{"key":"e_1_2_1_32_1","first-page":"270P","article-title":"SR 33589: A new amiodarone\u2010like antiarrhythmic agent","volume":"107","author":"MANNING A.S.","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(81)90140-X"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00107a001"},{"key":"e_1_2_1_35_1","first-page":"37","volume-title":"Computers in Endocrinology","author":"MCINTOSH J.A.R.","year":"1984"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(83)90004-7"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198609000-00025"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199204000-00001"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.1991.tb00747.x"},{"key":"e_1_2_1_40_1","first-page":"1805","article-title":"Tissue distribution of amiodarone and desethylamiodarone in rats after repeated oral administration of various amiodarone dosages","volume":"35","author":"PLOMP T.A.","year":"1985","journal-title":"Arzneim. Forsch."},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(76)90279-3"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1985.22"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(74)90222-X"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1949.tb27297.x"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.65.2.477"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1970.tb09891.x"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3495(88)82986-2"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198609000-00016"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199003000-00022"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01907754"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199204000-00010"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-5381.1995.tb16397.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1476-5381.1995.tb16397.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T08:14:38Z","timestamp":1698308078000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-5381.1995.tb16397.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,10]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,10]]}},"alternative-id":["10.1111\/j.1476-5381.1995.tb16397.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1476-5381.1995.tb16397.x","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,10]]},"assertion":[{"value":"2012-07-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}